LASSBio-331

N/A

Report date: 2021/12/28 13:57:07
NME

Base Information

Drug NameLASSBio-331
Drug Alias NameLASSBio-331
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversidade Federal Do Rio De Janeiro
China Registration ClassN/A

Develop Information

Active CompaniesUniversidade Federal Do Rio De Janeiro
Inactive CompaniesN/A
Active IndicationsDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A